- Home
- SOPH vs SCD Comparison
SOPH vs SCD Comparison
Compare SOPH & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- SCD
- Stock Information
- Founded
- SOPH 2011
- SCD 2003
- Country
- SOPH Switzerland
- SCD United States
- Employees
- SOPH N/A
- SCD N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- SCD Trusts Except Educational Religious and Charitable
- Sector
- SOPH Health Care
- SCD Finance
- Exchange
- SOPH Nasdaq
- SCD Nasdaq
- Market Cap
- SOPH 226.6M
- SCD N/A
- IPO Year
- SOPH 2021
- SCD N/A
- Fundamental
- Price
- SOPH $3.26
- SCD $16.71
- Analyst Decision
- SOPH Strong Buy
- SCD
- Analyst Count
- SOPH 3
- SCD 0
- Target Price
- SOPH $7.00
- SCD N/A
- AVG Volume (30 Days)
- SOPH 21.3K
- SCD 62.6K
- Earning Date
- SOPH 11-05-2024
- SCD 01-01-0001
- Dividend Yield
- SOPH N/A
- SCD 9.63%
- EPS Growth
- SOPH N/A
- SCD N/A
- EPS
- SOPH N/A
- SCD N/A
- Revenue
- SOPH $64,488,000.00
- SCD N/A
- Revenue This Year
- SOPH $7.20
- SCD N/A
- Revenue Next Year
- SOPH $15.71
- SCD N/A
- P/E Ratio
- SOPH N/A
- SCD N/A
- Revenue Growth
- SOPH 9.85
- SCD N/A
- 52 Week Low
- SOPH $2.70
- SCD $11.33
- 52 Week High
- SOPH $7.37
- SCD $15.87
- Technical
- Relative Strength Index (RSI)
- SOPH 46.64
- SCD 36.96
- Support Level
- SOPH $3.06
- SCD $17.45
- Resistance Level
- SOPH $3.47
- SCD $17.79
- Average True Range (ATR)
- SOPH 0.18
- SCD 0.37
- MACD
- SOPH -0.00
- SCD -0.14
- Stochastic Oscillator
- SOPH 45.45
- SCD 20.65
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.